U.S. Oil and Gas Stock News

NYSE:TDW
NYSE:TDWEnergy Services

Tidewater Board Shift Anderson Exit Puts Governance In Investor Focus

Tidewater (NYSE:TDW) director Darron M. Anderson will step down from the board at the 2026 Annual Meeting. The board will shrink from eight to seven members after Anderson’s planned departure. Anderson is not seeking reelection and is expected to serve out his current term on the Audit and Safety & Sustainability Committees. The company states his decision is not related to any disagreement with management or board policies. Tidewater comes into this board change with its shares at $82.4...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Assessing Amicus Therapeutics (FOLD) Valuation After Strong Long Term Shareholder Returns

Context for the Recent Move in Amicus Therapeutics (FOLD) Recent trading in Amicus Therapeutics (FOLD) puts the spotlight back on how investors are weighing its rare disease portfolio against current financial metrics, including revenue, profitability, and multi year total returns. See our latest analysis for Amicus Therapeutics. At a share price of US$14.41, recent trading has been fairly muted over days and weeks. However, the 1 year total shareholder return of 70.94% and 5 year total...
NYSE:CB
NYSE:CBInsurance

Chubb (CB) Valuation Check After Recent Share Pullback And Conflicting Fair Value Signals

Recent share performance and business snapshot With no single event driving headlines, Chubb (CB) has still drawn attention after a recent share pullback. This has invited investors to reassess the insurer’s US$124.2b market value and diversified global operations. See our latest analysis for Chubb. Chubb’s recent 6.4% one month share price pullback contrasts with a 2.9% year to date share price gain and a 9.0% one year total shareholder return. This points to moderating short term momentum...
NasdaqGS:NVMI
NasdaqGS:NVMISemiconductor

Is It Too Late To Consider Nova (NVMI) After A 136% One Year Surge?

If you are wondering whether Nova's share price still offers value after a big run, or if you may be late to the story, this breakdown can help frame what the current market price might be implying. Nova closed at US$440.72, with returns of 26.9% year to date and 136.4% over the last year. Over the last 7 days and 30 days, the stock has seen more muted moves of a 5.3% decline and a 0.4% gain, respectively. Recent coverage around Nova has focused on its role in the semiconductor equipment...
NasdaqGS:ENTG
NasdaqGS:ENTGSemiconductor

Assessing Entegris (ENTG) Valuation After TurboQuant Concerns Hit Semiconductor Sentiment

Market reaction and governance changes set the stage Entegris (ENTG) quickly came into focus after sector wide selling linked to concerns over Google’s TurboQuant algorithm and its potential effect on memory demand, just as shareholders prepare to vote on governance changes. See our latest analysis for Entegris. At a share price of US$113.59, Entegris has seen a 30 day share price return of a 14% decline. However, its 90 day share price return of 32.17% and 1 year total shareholder return of...
NYSE:DE
NYSE:DEMachinery

Is It Too Late To Consider Deere (DE) After Recent Share Price Swings?

Wondering if Deere at US$566.64 still offers value, or if most of the opportunity is already priced in. The stock's recent returns show a mixed picture, with a 1.2% gain over 7 days, a 10.0% decline over 30 days, and longer term returns of 21.4% year to date and 23.4% over 1 year. Recent news coverage has focused on Deere's role as a major machinery and equipment provider, which often puts the stock in the spotlight when investors reassess exposure to industrial and capital goods names. This...
NYSE:ADM
NYSE:ADMFood

ADM Pesticide Vote Tests ESG Transparency And Valuation Narrative

Shareholders have filed a proposal asking Archer-Daniels-Midland to disclose pesticide use data within its regenerative agriculture program. The proposal will be voted on at the upcoming annual general meeting. ADM has recommended that investors vote against the measure in its meeting materials. NYSE:ADM, recently trading at $72.23, has seen a 22.3% return year to date and a 56.2% return over the past year. The stock also shows a 44.1% return over five years, which keeps it on the radar for...
NYSE:KNSL
NYSE:KNSLInsurance

Is Rapid EPS and Specialty Premium Growth Altering The Investment Case For Kinsale Capital Group (KNSL)?

Kinsale Capital Group recently reported that its net premiums earned expanded by 21.2% annually over the last two years, reflecting robust demand for its specialty insurance coverage serving higher-risk, hard-to-place customers that many traditional carriers avoid. What stands out is that earnings per share grew at a very large annual rate over the past five years, outpacing revenue gains and indicating that new business written in this niche segment has been highly profitable and...
NasdaqCM:BYRN
NasdaqCM:BYRNAerospace & Defense

A Look At Byrna Technologies (BYRN) Valuation After The Appointment Of New President Luan Pham

Byrna Technologies (BYRN) has drawn fresh attention after appointing long time commercial leader Luan Pham as President, a move that highlights the company’s focus on execution in less lethal personal defense. See our latest analysis for Byrna Technologies. Despite Pham’s expanded remit and the upcoming presentation at the Roth Conference, recent share price momentum has been weak, with a 30 day share price return of 31.14% and a 1 year total shareholder return of 48.39%. However, the 3 year...
NYSE:CHH
NYSE:CHHHospitality

Assessing Choice Hotels (CHH) Valuation As Ascend Collection Surpasses 500 Properties And Global Footprint Expands

Expansion milestone puts Ascend Collection in focus Choice Hotels International (CHH) has crossed the 500 property mark for its Ascend Collection, supported by a 70 hotel pipeline and new openings across the U.S., Europe, Canada, Africa, Latin America, and China. See our latest analysis for Choice Hotels International. Despite the Ascend Collection expansion and recent loyalty program updates, Choice Hotels International’s 1 year total shareholder return of 22.75% contrasts with a 4.7% year...
NYSE:PRKS
NYSE:PRKSHospitality

A Look At United Parks & Resorts (PRKS) Valuation As DOJ Lawsuit Raises Accessibility Concerns

DOJ lawsuit puts accessibility and legal risk in focus for United Parks & Resorts (PRKS) The US Department of Justice has sued United Parks & Resorts (PRKS) over an alleged ban on certain walkers for guests with disabilities, raising fresh questions about legal risk, brand perception, and potential financial exposure. See our latest analysis for United Parks & Resorts. The DOJ lawsuit arrives after a weak share price run, with a 30 day share price return of a 14.54% decline and a 1 year total...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

Is RadNet’s (RDNT) Upgraded Imaging Center Guidance Reframing the Role of AI in Its Strategy?

RadNet recently presented at the 2026 KeyBanc Capital Markets Healthcare Virtual Forum, where Executive VP and CFO Mark D. Stolper discussed financial performance following a fiscal update showing 14.8% year-on-year revenue growth and margins supported by strong procedural volumes. The company also raised its 2025 revenue and adjusted EBITDA guidance for its Imaging Center segment, underscoring how operational improvements and its growing artificial intelligence division are increasingly...
NasdaqGS:HTZ
NasdaqGS:HTZTransportation

A Look At Hertz (HTZ) Valuation As Airport Delays Push Travelers Toward Rental Cars

Hertz Global Holdings (HTZ) is back in focus after a partial US government shutdown led to long airport security lines, which pushed more travelers to consider rental cars and increased interest in the stock. See our latest analysis for Hertz Global Holdings. The latest excitement around airport delays sits against a mixed record, with a 16.46% 7 day share price return contrasting with a 90 day share price return of negative 12.88% and a 3 year total shareholder return of negative 71.76%...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Madrigal Expands Beyond Rezdiffra With New RNA Licensing Deal

Madrigal Pharmaceuticals (NasdaqGS:MDGL) has entered an exclusive global licensing agreement with Suzhou Ribo Life Science and Ribocure. The deal covers six preclinical small interfering RNA programs and extends Madrigal's pipeline beyond its MASH therapy Rezdiffra. The companies expect to submit investigational new drug applications for the first siRNA candidates this year. Madrigal Pharmaceuticals is drawing fresh attention as it adds RNA based therapies to a portfolio that already...
NYSE:NBHC
NYSE:NBHCBanks

Is National Bank Holdings (NBHC) Offering Enough Value After Recent Share Price Softness

If you are wondering whether National Bank Holdings at around US$37.94 is giving you enough value for the risk you are taking, this breakdown will help you put the current share price in context. The stock has returned 1.2% over the last 7 days, is down 5.1% over the past month, and is roughly flat year to date at 0.1%, while the 1 year and 3 year returns sit at 1.1% and 24.3% respectively. These recent moves come as investors continue to assess National Bank Holdings' position in the US...
NYSE:DAN
NYSE:DANAuto Components

Assessing Dana (DAN) Valuation After The Dana 2030 Growth And Capital Return Plan

Why Dana 2030 is in focus Dana (DAN) has put its new Dana 2030 plan at center stage after Capital Markets Day, linking long term revenue and margin goals with a sizable program of share repurchases and dividends. See our latest analysis for Dana. The Dana 2030 announcement lands after a sharp shift in sentiment, with a 35.74% 90 day share price return and a very large 152.45% 1 year total shareholder return signaling strong recent momentum. If Dana 2030 has you thinking about what else could...
OTCPK:MUEL
OTCPK:MUELMachinery

Paul Mueller (OTCPK:MUEL) Shift To TTM Profitability Challenges Cautious Earnings Narratives

Paul Mueller (MUEL) opened FY 2025 with third quarter revenue of US$61.4 million and EPS of US$5.25, while trailing twelve month revenue sat at US$263.3 million and EPS at US$34.90. These figures reflect the company’s move into consistent profitability over the past year. Revenue has ranged from US$58.9 million to US$72.6 million across the last six reported quarters, with quarterly EPS moving between US$5.25 and US$17.80, giving investors a clear view of how margins have settled into a more...
NYSE:EGP
NYSE:EGPIndustrial REITs

A Look At EastGroup Properties (EGP) Valuation After Recent Share Price Pullback

What recent performance says about EastGroup Properties EastGroup Properties (EGP) has drawn attention after recent share price moves, with a last close of $183.17 and mixed short term returns that include a roughly 7% decline over the past month. For longer term holders, the stock shows a total return of about 7% over the past year and around 21% over the past 3 months. This gives investors a useful snapshot of how the REIT has traded recently. See our latest analysis for EastGroup...
NYSE:CRGY
NYSE:CRGYOil and Gas

Is It Time To Reassess Crescent Energy (CRGY) After Its Strong Year To Date Rally?

If you are wondering whether Crescent Energy's current share price reflects its underlying value, it helps to step back and look at the full picture before making any decisions. The stock last closed at US$13.70, with recent returns of 8.1% over 7 days, 17.5% over 30 days, 61.0% year to date and 29.2% over 1 year. This performance has put Crescent Energy firmly on many investors' watchlists. These moves have come as Crescent Energy continues to attract attention within the energy sector,...
NasdaqGS:RUSH.A
NasdaqGS:RUSH.ATrade Distributors

Rush Enterprises COO Shift Puts Spotlight On Valuation And Execution

Rush Enterprises appointed longtime executive Jody Pollard as Chief Operating Officer, following the departure of Jason Wilder. The leadership change places Pollard in a central role overseeing operations and executing company initiatives. The appointment is relevant for investors watching how management transitions may influence execution and operational priorities. Rush Enterprises, listed as NasdaqGS:RUSH.A, is trading at $66.08, with the share price reflecting a 22.2% return year to...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Is It Too Late To Revisit Fortinet (FTNT) After A 19% One Year Slide?

This article examines whether Fortinet, at around US$78 a share, still offers value or if most of the upside may already be reflected in the price, by looking at what the current market valuation might be implying. The stock has had a mixed run, with a 3.9% decline over the last 7 days and a 1.1% decline over the last 30 days, while the 1 year return sits at a 19.0% loss and the 3 and 5 year returns stand at 17.7% and 109.8% respectively. Recent attention on Fortinet has been influenced by...
NasdaqGS:CSGP
NasdaqGS:CSGPReal Estate

CoStar Brings On AI Expert Nana Banerjee As Investors Weigh Governance

CoStar Group (NasdaqGS:CSGP) has appointed Nana Banerjee as an Independent Director to its Board. Banerjee brings AI, technology, and data transformation experience from leading data focused companies. The appointment comes as CoStar Group faces questions around transparency and reporting practices. For investors watching CoStar Group at a share price of $39.77, the appointment comes after a weak recent track record for the stock. The share price shows a 7.3% decline over the past week,...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

A Look At NovoCure (NVCR) Valuation After Extended Share Price Weakness

NovoCure stock moves after recent performance shifts NovoCure (NVCR) is back on many investors’ screens after a recent stretch of weaker share performance, including negative returns over the past month, the past three months, and over the past year. See our latest analysis for NovoCure. The recent 1 day share price return of a 6.72% decline, adding to a 30 day share price return of a 19.75% decline and a 1 year total shareholder return of a 41.83% decline, suggests momentum has been fading...
NasdaqGS:DOCU
NasdaqGS:DOCUSoftware

Assessing DocuSign (DOCU) Valuation After Prolonged Share Price Weakness

DocuSign snapshot after recent share performance DocuSign (DOCU) has seen its share price move to US$45.71, with a return of about 1% over the past month and a decline of roughly 34% over the past 3 months. See our latest analysis for DocuSign. For context, DocuSign’s recent share price return shows short term stability but longer term pressure. The 30 day share price gain of 1.42% is set against a 1 year total shareholder return decline of 45.05% and a 5 year total shareholder return decline...